ORIC-101
101-18101
Phase 1 small_molecule terminated
Quick answer
ORIC-101 for Solid Tumor is a Phase 1 program (small_molecule) at Oric Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oric Pharmaceuticals
- Indication
- Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated